Belgium
Convert secures €13.6m grant to develop targeted chemo for oxygen-deprived tumours
March 9, 2018Medical Communications, Research and Development Belgium, Cancer, Convert pharma, chemotherapy, pharma
Belgium’s Convert Pharmaceuticals has secured a €13.6 million grant for initial development efforts on a new targeted chemotherapy drug which …
Sanofi invests €300 million in new Belgian biologics site
April 19, 2016Manufacturing and Production Belgium, Sanofi, belgian, flanders, geel, investment, manufacturing, pipeline
Sanofi has announced plans to expand its site in Geel, Belgium, with a €300 million investment to support its pipeline …
UCB sells generics business
November 10, 2014Manufacturing and Production, Sales and Marketing Belgium, UCB, generics, kremers urban, us conern
UCB is to sell its US generics business Kremers Urban to two private equity firms in a $1.5 billion deal. …
UCB opens Belgian pilot plant
September 17, 2012Manufacturing and Production Amgen, Belgium, R&D, UCB
UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …
Genzyme plans new Belgium facility
January 25, 2011Manufacturing and Production Belgium, Genzyme, Lumizyme, Myozyme, Pompe disease, Sanofi-Aventis, alglucosidase alfa
US rare disease drug specialist Genzyme, the subject of a hostile takeover offer from France’s Sanofi-Aventis, says that it will …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
